Epizyme reported 5.54M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amarin AMRN:US $ 225.77M 42.05M
Amgen AMGN:US $ 4554M 143M
Biogen BIIB:US $ 1294.2M 78.8M
Daiichi Sankyo 4568:JP Y 249309M 31399M
Eisai 4523:JP Y 103510M 4502M
Exelixis EXEL:US $ 33.02M 4.55M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 466400M 133900M
Karyopharm Therapeutics KPTI:US $ 3.47M 404K
Macrogenics MGNX:US $ 2.95M 1.65M
Novartis NOVN:VX SF 6880M 117M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M